MonaJuventa™ Nu (Scarlet Beebalm / Didymin)

It is an oral scarlet beebalm (Monarda didyma) extract from Mibelle, standardized to the flavonoid didymin and marketed for healthy aging, stress and sleep. Its trial reported a slower epigenetic-age gain and lower cortisol over 12 weeks.

MonaJuventa Nu's trial used an epigenetic biological-age measure, not lifespan, and was a single manufacturer-associated study. The cortisol and sleep findings are plausible; the anti-aging claim is intriguing but unproven and needs independent replication.

MonaJuventa Nu is researched primarily for Longevity, Stress & Anxiety, and Sleep Health. In a randomized, double-blind, placebo-controlled trial in stressed workers (45–65 y), 100 mg/day reduced the gain in a biological-age (epigenetic) measure and lowered cortisol versus placebo, with improvements in quality of life and sleep.

The clinically studied dose is Branded trial: 100 mg/day for 12 weeks. Taken as a capsule. Always follow the product label and check with a healthcare provider for personal advice.

For most healthy adults, MonaJuventa Nu is well tolerated at studied doses. Reported effects can include: Generally well tolerated in the available trial. Mild gastrointestinal upset possible. It may also interact with some medications. MonaJuventa Nu is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Possible interactions include: No clinically documented drug interactions; theoretical caution with sedatives given the sleep effect. Discuss with a clinician if on cortisol-affecting or psychiatric medications. If you take prescription medication, check with a pharmacist or doctor before using it.

NutraSmarts rates the evidence for MonaJuventa Nu as Limited (2 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.